FR901228 (romidepsin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FR901228 (romidepsin), covering 2012-08-22 to 2012-08-22. Get the full timeline:
Most recent: Clinical Trial Update: FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]